for Psychedelics
We support clinical development of natural psychedelics with validated testing, toxicological evaluation, and regulatory insight.

Why Broughton?
Psychedelic Compound
Testing Services
Deliver compliant testing of psilocybin, DMT, mescaline and other natural actives with precision analytical methods and advanced instrumentation.
Download our psychedelic testing overviewMethod Development & Analytical Chemistry
Design and validate methods for characterising complex botanical extracts using LC-MS, GC, and XRPD.
Download our method development overview
Stability Studies &
Controlled Storage
Support shelf-life claims and product quality with ICH-aligned stability testing and long-term storage under GMP conditions.
Download our stability testing guide
Toxicology & Safety
Assessment
Evaluate safety profiles of novel psychedelics and delivery formats with in-house toxicological expertise.
Download our toxicology services overview
Regulatory Strategy &
Clinical Support
Navigate UK and EU clinical development requirements with strategic guidance on data, documentation and MAA submissions.
Download our regulatory roadmap
Scientific Substantiation
& Dossier Preparation
Generate scientific data and documentation to support efficacy claims, risk assessments, and global market authorisation.
Download our scientific substantiation guide
Building Certainty, One Partnership at a Time
At Broughton, we measure success by the trust our clients place in us. As a global CRO, we work as an extension of our clients’ teams, delivering integrated analytical, scientific, and regulatory services that bring clarity and build certainty across pharmaceutical, healthcare, and lifestyle markets.
Expertise and Certainty in a Complex Regulatory Landscape - “We needed a partner who ensures strict compliance in highly regulated environments. Broughton provided the scientific expertise and operational certainty to help us deliver safe, effective medicines while accelerating our path to market.”
Regulatory Affairs Director, Specialty Pharma Company
A True Extension of Our Team - “In healthcare, balancing innovation with compliance is key. Broughton guided us through moderate regulation with practical insights and responsive support. They’re more than a service provider—they’re a trusted part of our team.”
Head of Product Development, HealthTech Innovator
Trusted Support in Emerging Markets -“In emerging markets, we need agility and credibility. Broughton helped us navigate minimal regulation while maintaining high safety and quality standards. Their insight gave us the confidence to scale faster.”– Innovation Lead, Lifestyle Brand
Head of Product Development, HealthTech Innovator
Products We Support
We support academic researchers, biotech innovators, and clinical sponsors developing natural psychedelic therapies for conditions such as depression, PTSD, and addiction. Psychedelic types we support include:
Psilocybin and psilocin (e.g. magic mushroom extracts)
Ayahuasca-based preparations (DMT + MAO inhibitors)
Ibogaine and derivatives
Mescaline from natural sources


Our Expertise
Research and Development: Early-stage scientific input to guide product formulation, safety strategy, and testing design.
Scientific Substantiation: Analytical testing and toxicological assessment to support product safety, efficacy, and regulatory compliance.
Post-Market Compliance: Ongoing testing, documentation, and regulatory support to ensure continued product quality and market readiness.
Our team works as an extension of yours, helping you reduce risk, accelerate timelines, and bring products to market responsibly.
Knowledge Centre
Explore expert insights and technical guidance to support medicinal psychedelic development.